Background: Convalescent plasma is a potential therapeutic option for critically ill patients with coronavirus disease 19 (COVID-19), yet its efficacy remains to be determined. The aim was to investigate the effects of convalescent plasma (CP) in critically ill patients with COVID-19. Methods: This was a single-center prospective observational study conducted in Rio de Janeiro, Brazil, from March 17th to May 30th, with final follow-up on June 30th. We included 113 laboratory-confirmed COVID-19 patients with respiratory failure. Primary outcomes were time to clinical improvement and survival within 28 days. Secondary outcomes included behavior of biomarkers and viral loads. Kaplan-Meier analyses and Cox proportional-hazards regression using propensity score with inverse-probability weighing were performed. Results: 41 patients received CP and 72 received standard of care (SOC). Median age was 61 years (IQR 48-68), disease duration was 10 days (IQR 6-13), and 86% were mechanically ventilated. At least 29 out of 41CP-recipients had baseline IgG titers ≥ 1:1,080. Clinical improvement within 28 days occurred in 19 (46%) CP-treated patients, as compared to 23 (32%) in the SOC group [adjusted hazard ratio (aHR) 0.91 (0.49-1.69)]. There was no significant change in 28-day mortality (CP 49% vs. SOC 56%; aHR 0.90 [0.52-1.57]). Biomarker assessment revealed reduced inflammatory activity and increased lymphocyte count after CP. Conclusions: In this study, CP was not associated with clinical improvement or increase in 28-day survival. However, our study may have been underpowered and included patients with high IgG titers and life-threatening disease. Clinical Trial Registration: The study protocol was retrospectively registered at the Brazilian Registry of Clinical Trials (ReBEC) with the identification RBR-4vm3yy (http://www.ensaiosclinicos.gov.br).
Background: Convalescent plasma is a potential therapeutic option for critically illpatients with coronavirus disease 19 (COVID-19), yet its efficacy remains to be determined. The aim was to investigate the effects of convalescent plasma (CP) in critically illpatients with COVID-19. Methods: This was a single-center prospective observational study conducted in Rio de Janeiro, Brazil, from March 17th to May 30th, with final follow-up on June 30th. We included 113 laboratory-confirmed COVID-19patients with respiratory failure. Primary outcomes were time to clinical improvement and survival within 28 days. Secondary outcomes included behavior of biomarkers and viral loads. Kaplan-Meier analyses and Cox proportional-hazards regression using propensity score with inverse-probability weighing were performed. Results: 41 patients received CP and 72 received standard of care (SOC). Median age was 61 years (IQR 48-68), disease duration was 10 days (IQR 6-13), and 86% were mechanically ventilated. At least 29 out of 41CP-recipients had baseline IgG titers ≥ 1:1,080. Clinical improvement within 28 days occurred in 19 (46%) CP-treated patients, as compared to 23 (32%) in the SOC group [adjusted hazard ratio (aHR) 0.91 (0.49-1.69)]. There was no significant change in 28-day mortality (CP 49% vs. SOC 56%; aHR 0.90 [0.52-1.57]). Biomarker assessment revealed reduced inflammatory activity and increased lymphocyte count after CP. Conclusions: In this study, CP was not associated with clinical improvement or increase in 28-day survival. However, our study may have been underpowered and included patients with high IgG titers and life-threatening disease. Clinical Trial Registration: The study protocol was retrospectively registered at the Brazilian Registry of Clinical Trials (ReBEC) with the identification RBR-4vm3yy (http://www.ensaiosclinicos.gov.br).
Authors: Michael J Joyner; R Scott Wright; DeLisa Fairweather; Jonathon W Senefeld; Katelyn A Bruno; Stephen A Klassen; Rickey E Carter; Allan M Klompas; Chad C Wiggins; John Ra Shepherd; Robert F Rea; Emily R Whelan; Andrew J Clayburn; Matthew R Spiegel; Patrick W Johnson; Elizabeth R Lesser; Sarah E Baker; Kathryn F Larson; Juan G Ripoll; Kylie J Andersen; David O Hodge; Katie L Kunze; Matthew R Buras; Matthew Np Vogt; Vitaly Herasevich; Joshua J Dennis; Riley J Regimbal; Philippe R Bauer; Janis E Blair; Camille M van Buskirk; Jeffrey L Winters; James R Stubbs; Nigel S Paneth; Nicole C Verdun; Peter Marks; Arturo Casadevall Journal: J Clin Invest Date: 2020-06-11 Impact factor: 14.808
Authors: J L Vincent; R Moreno; J Takala; S Willatts; A De Mendonça; H Bruining; C K Reinhart; P M Suter; L G Thijs Journal: Intensive Care Med Date: 1996-07 Impact factor: 17.440
Authors: Shruti Gupta; Salim S Hayek; Wei Wang; Lili Chan; Kusum S Mathews; Michal L Melamed; Samantha K Brenner; Amanda Leonberg-Yoo; Edward J Schenck; Jared Radbel; Jochen Reiser; Anip Bansal; Anand Srivastava; Yan Zhou; Anne Sutherland; Adam Green; Alexandre M Shehata; Nitender Goyal; Anitha Vijayan; Juan Carlos Q Velez; Shahzad Shaefi; Chirag R Parikh; Justin Arunthamakun; Ambarish M Athavale; Allon N Friedman; Samuel A P Short; Zoe A Kibbelaar; Samah Abu Omar; Andrew J Admon; John P Donnelly; Hayley B Gershengorn; Miguel A Hernán; Matthew W Semler; David E Leaf Journal: JAMA Intern Med Date: 2020-11-01 Impact factor: 21.873
Authors: Judith A Aberg; Nicole M Bouvier; Sean T H Liu; Hung-Mo Lin; Ian Baine; Ania Wajnberg; Jeffrey P Gumprecht; Farah Rahman; Denise Rodriguez; Pranai Tandon; Adel Bassily-Marcus; Jeffrey Bander; Charles Sanky; Amy Dupper; Allen Zheng; Freddy T Nguyen; Fatima Amanat; Daniel Stadlbauer; Deena R Altman; Benjamin K Chen; Florian Krammer; Damodara Rao Mendu; Adolfo Firpo-Betancourt; Matthew A Levin; Emilia Bagiella; Arturo Casadevall; Carlos Cordon-Cardo; Jeffrey S Jhang; Suzanne A Arinsburg; David L Reich Journal: Nat Med Date: 2020-09-15 Impact factor: 53.440
Authors: Giacomo Grasselli; Massimiliano Greco; Alberto Zanella; Giovanni Albano; Massimo Antonelli; Giacomo Bellani; Ezio Bonanomi; Luca Cabrini; Eleonora Carlesso; Gianpaolo Castelli; Sergio Cattaneo; Danilo Cereda; Sergio Colombo; Antonio Coluccello; Giuseppe Crescini; Andrea Forastieri Molinari; Giuseppe Foti; Roberto Fumagalli; Giorgio Antonio Iotti; Thomas Langer; Nicola Latronico; Ferdinando Luca Lorini; Francesco Mojoli; Giuseppe Natalini; Carla Maria Pessina; Vito Marco Ranieri; Roberto Rech; Luigia Scudeller; Antonio Rosano; Enrico Storti; B Taylor Thompson; Marcello Tirani; Pier Giorgio Villani; Antonio Pesenti; Maurizio Cecconi Journal: JAMA Intern Med Date: 2020-10-01 Impact factor: 21.873
Authors: Annemarie B Docherty; Ewen M Harrison; Christopher A Green; Hayley E Hardwick; Riinu Pius; Lisa Norman; Karl A Holden; Jonathan M Read; Frank Dondelinger; Gail Carson; Laura Merson; James Lee; Daniel Plotkin; Louise Sigfrid; Sophie Halpin; Clare Jackson; Carrol Gamble; Peter W Horby; Jonathan S Nguyen-Van-Tam; Antonia Ho; Clark D Russell; Jake Dunning; Peter Jm Openshaw; J Kenneth Baillie; Malcolm G Semple Journal: BMJ Date: 2020-05-22
Authors: Ventura A Simonovich; Leandro D Burgos Pratx; Paula Scibona; María V Beruto; Marcelo G Vallone; Carolina Vázquez; Nadia Savoy; Diego H Giunta; Lucía G Pérez; Marisa Del L Sánchez; Andrea Vanesa Gamarnik; Diego S Ojeda; Diego M Santoro; Pablo J Camino; Sebastian Antelo; Karina Rainero; Gabriela P Vidiella; Erica A Miyazaki; Wanda Cornistein; Omar A Trabadelo; Fernando M Ross; Mariano Spotti; Gabriel Funtowicz; Walter E Scordo; Marcelo H Losso; Inés Ferniot; Pablo E Pardo; Eulalia Rodriguez; Pablo Rucci; Julieta Pasquali; Nora A Fuentes; Mariano Esperatti; Gerardo A Speroni; Esteban C Nannini; Alejandra Matteaccio; Hernán G Michelangelo; Dean Follmann; H Clifford Lane; Waldo H Belloso Journal: N Engl J Med Date: 2020-11-24 Impact factor: 91.245
Authors: H S C Paula; S B Santiago; L A Araújo; C F Pedroso; T A Marinho; I A J Gonçalves; T A P Santos; R S Pinheiro; G A Oliveira; K A Batista Journal: Braz J Med Biol Res Date: 2021-12-10 Impact factor: 2.590
Authors: Maddalena Marconato; Irene A Abela; Anthony Hauser; Magdalena Schwarzmüller; Rheliana Katzensteiner; Dominique L Braun; Selina Epp; Annette Audigé; Jacqueline Weber; Peter Rusert; Eméry Schindler; Chloé Pasin; Emily West; Jürg Böni; Verena Kufner; Michael Huber; Maryam Zaheri; Stefan Schmutz; Beat M Frey; Roger D Kouyos; Huldrych F Günthard; Markus G Manz; Alexandra Trkola Journal: J Clin Invest Date: 2022-06-15 Impact factor: 19.456
Authors: Stephen A Klassen; Jonathon W Senefeld; Katherine A Senese; Patrick W Johnson; Chad C Wiggins; Sarah E Baker; Noud van Helmond; Katelyn A Bruno; Liise-Anne Pirofski; Shmuel Shoham; Brenda J Grossman; Jeffrey P Henderson; R Scott Wright; DeLisa Fairweather; Nigel S Paneth; Rickey E Carter; Arturo Casadevall; Michael J Joyner Journal: Front Med (Lausanne) Date: 2021-06-07